146 related articles for article (PubMed ID: 7903057)
21. Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies.
Osapay G; Prokai L; Kim HS; Medzihradszky KF; Coy DH; Liapakis G; Reisine T; Melacini G; Zhu Q; Wang SH; Mattern RH; Goodman M
J Med Chem; 1997 Jul; 40(14):2241-51. PubMed ID: 9216843
[TBL] [Abstract][Full Text] [Related]
22. Novel antitumor peptide hormones and their effect on signal transduction.
Kéri G; Balogh A; Horváth A; Mezö I; Vadász Z; Bökönyi G; Bajor T; Vántus T; Teplán I; Horváth J
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):105-10. PubMed ID: 1356011
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan.
Erchegyi J; Hoeger CA; Low W; Hoyer D; Waser B; Eltschinger V; Schaer JC; Cescato R; Reubi JC; Rivier JE
J Med Chem; 2005 Jan; 48(2):507-14. PubMed ID: 15658864
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of somatostatin analogues on proliferation of murine colonic cancer cells in vitro.
Pawlikowski M; Kunert-Radek J; Winczyk K
Cytobios; 1997; 89(358-359):183-7. PubMed ID: 9418016
[TBL] [Abstract][Full Text] [Related]
25. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, Cytotoxicity and Antioxidant Activity of New Analogs of RC-121 Synthetic Derivatives of Somatostatin.
Naydenova E; Wesselinova D; Staykova S; Goshev I; Vezenkov L
Anticancer Agents Med Chem; 2018; 18(10):1417-1424. PubMed ID: 29667555
[TBL] [Abstract][Full Text] [Related]
27. The history of somatostatin analogs.
Pless J
J Endocrinol Invest; 2005; 28(11 Suppl International):1-4. PubMed ID: 16625837
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships.
Mezö I; Lovas S; Pályi I; Vincze B; Kálnay A; Turi G; Vadász Z; Seprödi J; Idei M; Tóth G; Gulyás E; Otvös F; Mák M; Horváth JE; Teplán I; Murphy RF
J Med Chem; 1997 Oct; 40(21):3353-8. PubMed ID: 9341910
[TBL] [Abstract][Full Text] [Related]
29. Influence of various administration routes on the antitumor efficacy ofTT-232, a novel somatostatin analog.
Tejeda M; Gaal D; Schwab RE; Pap A; Szúts T; Keri G
Anticancer Res; 2000; 20(2A):1023-7. PubMed ID: 10810391
[TBL] [Abstract][Full Text] [Related]
30. Antitumor studies -- part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase.
Ali HI; Tomita K; Akaho E; Kunishima M; Kawashima Y; Yamagishi T; Ikeya H; Nagamatsu T
Eur J Med Chem; 2008 Jul; 43(7):1376-89. PubMed ID: 18055068
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Pinski J; Reile H; Halmos G; Groot K; Schally AV
Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids.
Naydenova E; Wesselinova D; Staykova S; Danalev D; Dzimbova T
Amino Acids; 2019 Sep; 51(9):1247-1257. PubMed ID: 31350614
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia.
Pintér E; Helyes Z; Németh J; Pórszász R; Pethö G; Thán M; Kéri G; Horváth A; Jakab B; Szolcsányi J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):142-50. PubMed ID: 12122501
[TBL] [Abstract][Full Text] [Related]
35. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.
Beyermann M; Fechner K; Furkert J; Krause E; Bienert M
J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
[TBL] [Abstract][Full Text] [Related]
37. Novel side-chain glucosylated and adamantylated [Asp(2)/Glu(2)]enkephalin analogs: synthesis and in vitro growth inhibition of human tumor cells.
Horvat S; Kralj M; Perc M; Jerić I; Varga-Defterdarović L; Jakas A; Roscić M; Suman L; Gredicak M
Chem Biol Drug Des; 2009 Feb; 73(2):253-7. PubMed ID: 19207428
[TBL] [Abstract][Full Text] [Related]
38. Bombesin analogs containing alpha-amino-isobutyric acid with potent anticancer activity.
Prasad S; Mathur A; Gupta N; Jaggi M; Singh AT; Rajendran P; Sanna VK; Datta K; Mukherjee R
J Pept Sci; 2007 Jan; 13(1):54-62. PubMed ID: 17031871
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the tumor growth inhibitory effect of intermittent and continuous administration of the somatostatin structural derivative TT-232 in various human tumor models.
Tejeda M; Gaál D; Hullán L; Csuka O; Schwab R; Szokoloczi O; Kéri G
Anticancer Res; 2006; 26(4B):3011-5. PubMed ID: 16886628
[TBL] [Abstract][Full Text] [Related]
40. Effects of side-chain characteristics on stability and oligomerization state of a de novo-designed model coiled-coil: 20 amino acid substitutions in position "d".
Tripet B; Wagschal K; Lavigne P; Mant CT; Hodges RS
J Mol Biol; 2000 Jul; 300(2):377-402. PubMed ID: 10873472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
